Betsi Cadwaladr University Health Board

Specialist MDT: Betsi Cadwaladr University Health Board

View Provider Services

The following services are available at this Health Board (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • External beam radiotherapy (EBRT)
    • Chemotherapy
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 567 567
Performance Status recorded 100% 100%
PSA completed 90% 90%
Gleason Score completed 90% 90%
TNM completed 61% 61%
Risk group assigned 89% 89%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 526 34801
Percentage of men diagnosed with metastatic disease 13% 13%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 18 N/A
Percentage of men with low-risk localised disease receiving radical treatment 0% 0%
No. of men diagnosed with locally advanced disease 217 N/A
Percentage of men diagnosed with locally advanced disease receiving radical treatment 72% 0%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2019-2020) 34
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 15%
No. of men who received radical prostatectomy (2018) 37
Adjusted percentage of men experiencing at least one GU complication (%) 2%
No. of men who received radical radiotherapy (2018) 195
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%) 13%

Compare provider outcomes